Macrolide immunosuppressants

Authors
Citation
U. Mrowietz, Macrolide immunosuppressants, EUR J DERM, 9(5), 1999, pp. 346-351
Citations number
52
Categorie Soggetti
da verificare
Journal title
EUROPEAN JOURNAL OF DERMATOLOGY
ISSN journal
11671122 → ACNP
Volume
9
Issue
5
Year of publication
1999
Pages
346 - 351
Database
ISI
SICI code
1167-1122(199907/08)9:5<346:MI>2.0.ZU;2-6
Abstract
Macrolide immunosuppressants are a new class of compounds sharing a macroli de-like structure and potent immunosuppressive activity in vitro and in viv o. Tacrolimus, the best known substance of this group, is registered in man y countries for the prevention of transplant rejection. Numerous new substa nces of this group are in the pipelines of the pharmaceutical industries. M acrolide immunosuppressants are also effective in dermatological disorders. Due to their chemical structure these compounds can be used for topical tr eatment. Clinical studies have already shown highly effective topical thera py of atopic dermatitis with tacrolimus and the ascomycin derivative SDZ AS M 981, another macrolide immunosuppressant. In this article the pharmacological aspects of macrolide immunosuppressants , their supposed mechanisms of action, pre-clinical and clinical experience are reviewed.